General Information

Precithera, Inc.

	Address	1010 Sherbrooke Street West Suite 408 Montréal, H3A 2R7 Canada
	Address type	Registered Office Address
	Address province	Quebec

	Corporation ID	9767665
	Business number	767509722
	Status	Dissolved
	ACT	Canada Business Corporations Act
	Status details	Dissolved by the corporation
	Anniversary date	05/26/2016
	Last annual filing	2021
	Data verified	10/31/2026

Description

Precithera, Inc. is a dissolved company which was registered under Canada Business Corporations Act with a corporation number 9767665 (business no 767509722). The incorporation was performed on 2016-05-26. The company is located in Montréal at 1010 Sherbrooke Street West, Suite 408, H3A 2R7 in Quebec administrative division. To our knowledge, the most recent annual meeting was held on 2017-07-18.
Additional corporations in the vicinity include: 131608 Canada Inc., Gloria Bass Design Inc., Beanstox Investments Inc., Stanton Asset Management Inc., Tonus Capital Inc..

Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).

Company names

Name	Effective date	Type	Current
PRECITHERA, INC.	05/26/2016	Corporate Name	true

Directors

Youssef Lemgendez
,

Richard Labaudinière
,

Sean Karamchandani
,

Laurence Rulleau
,

Robert G. McNeil
,

Philippe CRINE
,

last updated: 2026-10-30

Government Grants and Contributions

4 federal grants and contributions between 2018 and 2020 with a total value of $144,000.

Start date	Department and program	Value
12/20/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2.5 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.	$5,419
06/25/2020	National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2	$14,426
04/01/2020	National Research Council Canada Innovation Assistance Program (contribution) The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.	$10,164
06/01/2018	National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Development of Biologic to Treat Osteogenesis Imperfecta Development of a new protein therapeutic targeting a biological pathway recently shown to be involved in the development of rare diseases.	$113,991

Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.

Company activities

Date	Type	Section
07/26/2017	Amendment	8
05/26/2016	Incorporation

Company annual return

Meeting date	Type of corporation	Year of filing
07/18/2017	Non-distributing corporation with 50 or fewer shareholders	2017